The Claim
Aortic atherosclerotic plaque volume can be measured reproducibly using combined transesophageal and surface MRI, with a 4.8% coefficient of variation, enabling detection of clinically meaningful regression as early as 6 months after statin initiation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Combined transesophageal and surface MRI can measure changes in aortic plaque volume with 4.8% precision, allowing detection of plaque reduction as early as six months after starting statin therapy.
See the scientific wording
Aortic atherosclerotic plaque volume can be measured reproducibly using combined transesophageal and surface MRI, with a 4.8% coefficient of variation, enabling detection of clinically meaningful regression as early as 6 months after statin initiation.
Lowering cholesterol in the blood creates a pull that draws cholesterol out of artery gunk, causing the gunk to shrink and the artery wall to thin slightly, which allows precise scans to detect the change within six months.
What the research says
1 studyDoctors used a special MRI scan to measure gunk in an artery before and after 6 months of cholesterol-lowering medicine, and found the gunk shrank — and the scan was so precise it could detect even small changes like 4.8%.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.